Glyburide Tablet
Product Images NDC 51655-492

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 51655-492). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 492 25 Master Bottle Label Approval Rev A 02 22)

This is a description of a medication named "GLYBURIDE" manufactured by Avet Pharmaceuticals, Inc. It's a U.S. Food and Drug Administration (FDA) approved medication that comes in the form of tablets. The National Drug Code (NDC) is 51655-492-25, and the Lot number is 00. Each tablet contains 5mg of the medication. The medication is repackaged by Northwind Pharmaceuticals and should be stored at 20° - 25°C (687 - 77°F). Additional information can be found on the package insert.*

FDA Label Image

Image (Dde70749 E2c1 4ba6 Bdba F08a456e803c 01)

FDA Label Image

Logo (Dde70749 E2c1 4ba6 Bdba F08a456e803c 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.